TEG® 6s Heparin Neutralization Cartridge for Hemostatic Assessment of Patients Undergoing Cardiovascular Surgery
This study provided clinical validation for the TEG 6s heparin neutralization cartridge for point-of-care coagulation testing in patients undergoing cardiovascular surgeries or procedures. Further prospective trials with clinical endpoints are needed to determine the clinical utility of this cartridge.
Authors
- Hunter B. Moore (ORCID: https://orcid.org/0000-0002-5939-3828)
- Shaun Yockelson (ORCID: https://orcid.org/0000-0002-4828-6437)
- Leigh Anne Dageforde (ORCID: https://orcid.org/0000-0001-9706-1771)
- Jan Hartmann (ORCID: https://orcid.org/0000-0003-4978-8014)
- Hovig V. Chitilian
- Tetsuro Sakai (ORCID: https://orcid.org/0000-0003-2878-3775)
- Dieter Adelmann (ORCID: https://orcid.org/0000-0001-7645-3530)
- Paul A. Gurbel (ORCID: https://orcid.org/0000-0002-7289-0036)
- Kevin P. Bliden
- Udaya Tantry
- Kathirvel Subramaniam
- Michael Little
Institutions
- University of North Carolina at Chapel Hill (US)
- Harvard University (US)
- The University of Queensland (AU)
- The University of Texas at San Antonio Health Science Center (US)
- University of California, San Francisco (US)
- Ochsner Medical Center (US)
- Porter Adventist Hospital (US)
- Sinai Hospital (US)
- Massachusetts General Hospital (US)
- Nova Medical (United States) (US)
- Haemonetics (United States) (US)
- University of Pittsburgh Medical Center (US)
- Center for Pain and the Brain (US)
Publication Details
- Journal
- Anesthesiology
- Published
- 2025-09-18
- DOI
- https://doi.org/10.1097/aln.0000000000005759
- Citations
- 2
- Primary Topic
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Type
- article
- Field-Weighted Citation Impact
- 3.09